Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Sorrento Therapeutics Awarded NIH Grant for MRSA Program

May 21, 2010 By Bio-Medicine.Org

SAN DIEGO, May 21 /PRNewswire-FirstCall/ — Sorrento
Therapeutics, Inc. (OTC Bulletin Board: SRNE) today announced that
it has received an Advanced Technology Small Business Technology
Transfer Research (STTR) grant from the National Institute of
Allergy and Infectious Diseases. The peer-reviewed grant was
awarded to support the Company’s program to generate and develop
novel antibody therapeutics and vaccines to combat
Staphylococcus aureus (S. aureus or “Staph”)
infections, including methicillin-resistant S. aureus
(MRSA), by disrupting quorum sensing, a bacterial communication
process essential to virulence. The Phase I grant is for $300,000 annually for two years, with the
possibility of Phase II funding of $1
million
per year for up to 3 years.

“It is clear that the NIH is highly motivated to fund novel
approaches to tackling the serious healthcare burden of MRSA. We
believe our program to develop potential vaccines and antibody
therapeutics against MRSA holds great clinical promise because of
the high morbidity and mortality caused by this pathogen and the
limited treatment options available today,” said Antonius Schuh,
Ph.D., Chairman and Chief Executive Officer of Sorrento
Therapeutics.

Sorrento Therapeutics’ MRSA program targets specific
auto-inducing peptides (AIPs) central to the quorum sensing system
of S. aureus, which induces bacterial virulence.
Masking these AIPs leads to a disruption of bacterial communication
(“quorum quenching”) and suppresses virulence. In recommending the
grant application for funding, expert panel reviewers noted that
targeting quorum sensing and the virulence factors of S.
aureus
represented a paradigm shift, which could result in
fewer side effects than conventional drug therapies. Th

‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech